Programa de seguimiento farmacoterapéutico integral a pacientes crónicos y polimedicados. Programa Piloto en pacientes con Diabetes tipo 2. Resultados

  1. Nerea Ullibarri 1
  2. Miguel Ángel Gastelurrutia 2
  3. Flavia Erazo 3
  4. Milagros López de Ocáriz 4
  5. Amaia Martiarena 1
  6. Diez, Blanca 3
  7. Miriam Sáenz de Santamaria 4
  8. Villacorta, Mercedes 4
  9. Juan del-Arco 3
  10. Goyenechea, Estibaliz 5
  11. Braceras, Leire 1
  12. Jon Iñaki Betolaza 1
  1. 1 Dirección de Farmacia del Gobierno Vasco
  2. 2 Farmacéutico comunitario, Grupo de Investigación en Atención Farmacéutica, Universidad de Granad, Granada España.
  3. 3 Colegio oficial de Farmacéuticos de Bizkaia
  4. 4 Colegio oficial de Farmacéuticos de Alava
  5. 5 Colegio oficial de Farmacéuticos de Gipuzkoa
Show affiliations +
Journal:
Pharmaceutical care España

ISSN: 1139-6202

Year of publication: 2022

Volume: 24

Issue: 6

Pages: 35-65

Type: Article

DIALNET GOOGLE SCHOLAR lock_openOpen access editor

More publications in: Pharmaceutical care España

Abstract

Introduction: Basque community pharmacy has a long tradition of collaborating with Basque health authorities. In May 2017, a collaboration agreement was signed between the Department of Health and the three Basque Pharmaceutical Associations "for the implementation of a Pilot Program for Medi-cation review with follow up service for chronic polymedicated patients". Method: The medication review with follow up service was carried out in pharmacies of three integrated health organizations in Alava, Bizkaia and Gipuzkoa. 18 pharmacies participated with 7 patients each. Inclusion criteria: patients with type 2 diabetes who were taking 8 or more medicines. During the 12 months of the study, three points were analyzed: baseline (V1), 6 months (V2) and at the end of the study (V3).Results: Of the 127 initially planned patients, 87 completed the study. No significant differences were obtained in the HbA1c value between baseline and the end. In contrast, the number of uncontro-lled health problems decreased by 47% (p=0.001) without changing the number of medications. The most frequent DRPs in V3 were insufficient knowle-dge of the medication (34%) and lack of adherence (19%). Both, knowledge and adherence (p<0.001) and quality of life (p<0.05) improved.Conclusions: Although the program has not had an impact on the value of HbA1c, it has contributed to controlling other health problems, as well as adher-ence, knowledge about medications and the quality of life of patients.

Bibliographic References

  • Gastelurrutia MA, Larrañaga B, Garay A, Echeveste FA. Intervención desde la farmacia comunitaria a pacientes atendidos en los servicios de ayuda domiciliaria municipal. FARMACÉUTICOS COMUNITARIOS 2010; 2(1): 15-20
  • Osakidetza. Memoria del Plan del SIDA y Enfermedades de Transmisión Sexual. 2020. https://www.osakidetza.euskadi.eus/contenidos/informacion/osk_osaesk_salud_sex_vih/es_def/adjuntos/Memoria_VIH_2020_v2.pdf (Acceso, octubre 2021)
  • Encuesta de Salud de la CAPV 2018. Departamento de Salud del Gobierno Vasco. https://www.euskadi.eus/informacion/encuesta-de-salud-2017-2018/web01-a3osag17/es/ (Acceso, marzo 2022)
  • Guía de diabetes tipo 2 para clínicos: Recomendaciones de la redGDPS. Fundación redGDPS,2018. https://www.redgdps.org/gestor/upload/colecciones/Guia%20DM2_web.pdf (Acceso, marzo 2022)
  • Huang ES. Management of diabetes mellitus in older people with comorbidities. BMJ. 2016 Jun 15;353:i2200. doi: 10.1136/bmj.i2200
  • Gómez-Huelgas R, Gómez Peralta F, Rodríguez Mañas L, Formiga F, Puig Domingo M, Mediavilla Bravo JJ, et al. Tratamiento de la diabetes tipo 2 en el paciente anciano. Med Clin (Barc). 2013;140(3):134.e1-134.e12. doi: 10.1016/j.medcli.2012.10.003.
  • Jódar-Sánchez F, Malet-Larrea A, Martín JJ, García-Mochón L, López del Amo MP, Martínez-Martínez F, et al. Cost-Utility Analysis of a Medication Review with Follow-Up Service for Older Adults with Polypharmacy in Community Pharmacies in Spain: The conSIGUE Program. PharmacoEconomics 2015; 33(6):599-610. doi: 10.1007/s40273-015-0270-2
  • Wali H, Hudani Z, Wali S, Mercer K, Grindrod K. A systematic review of interventions to improve medication information for low health literate populations. Res Social Adm Pharm. 2016;12(6):830-864. doi: 10.1016/j.sapharm.2015.12.001.
  • Rajiah K, Sivarasa S, Maharajan MK. Impact of Pharmacists' Interventions and Patients' Decision on Health Outcomes in Terms of Medication Adherence and Quality Use of Medicines among Patients Attending Community Pharmacies: A Systematic Review. Int J Environ Res Public Health. 2021 Apr 21;18(9):4392. doi: 10.3390/ijerph18094392.
  • The World Health Report 2002: Reducing Risks, Promoting Healthy Life. Geneva, World Health Organization, 2002. https://apps.who.int/iris/bitstream/handle/10665/42510/WHR_2002.pdf?sequence=1 (Acceso, marzo 2022)
  • Entrevista Clínica. Manual de estrategias prácticas. Francesc Borrell i Carrió. Editorial: SEMFYC. https://www.semfyc.es/wp-content/uploads/2016/05/EntrevistaClinica_Borrell.pdf (Acceso, marzo 2022)
  • Sáez-Benito L, Fernandez-Llimos F, Feletto E, Gastelurrutia MA, Martinez-Martinez F, Benrimoj SI. Evidence of the clinical effectiveness of cognitive pharmaceutical services for aged patients. Age Ageing. 2013;42(4):442–9. doi: 10.1093/ageing/aft045
  • Varas-Doval R, Saéz-Benito L, Gastelurrutia MA, Benrimoj SI, Garcia-Cardenas V, Martinez-Martínez F. Systematic review of pragmatic randomised control trials assessing the effectiveness of professional pharmacy services in community pharmacies. BMC Health Serv Res. 2021 Feb 17;21(1):156. doi: 10.1186/s12913-021-06150-8.
Data source: Dialnet